Navigation Links
Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
Date:12/10/2007

Conference Call Scheduled for 4:00 p.m. Eastern Time to Review Clinical Trial Results for SNS-595 and Non-clinical Data for SNS-032 Presented at

the ASH Meeting

ATLANTA, Dec. 10 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a clinical-stage biopharmaceutical company developing novel anticancer therapeutics, presented positive results for SNS-595 in relapsed or refractory acute leukemia patients in an oral session by Jeffrey Lancet, M.D, Assistant Professor, Division of Hematologic Malignancies at the H. Lee Moffitt Cancer Center & Research Institute, at the 49th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia. In a Phase 1 clinical trial, SNS-595 was generally well tolerated with anti-leukemic clinical activity when administered either once- or twice-weekly at biologically active doses.

In addition, non-clinical data showing that SNS-032 induces apoptosis in chronic lymphocytic leukemia (CLL) cells are being presented by William Plunkett, Ph.D., Professor and Chief, Section of Molecular and Cellular Oncology at the University of Texas M. D. Anderson, in a poster session. SNS-032 is currently in a Phase 1 clinical trial in patients with CLL or multiple myeloma.

Sunesis management will host a conference call today at 4:00 p.m. Eastern time to review the SNS-595 and SNS-032 data presented at the ASH meeting. Drs. Lancet and Plunkett will join management on the call.

Oral Presentation: A Phase 1b Open-Label Study of the Novel DNA Replication Inhibitor SNS-595 in Refractory Acute Leukemia (Abstract #442)

SNS-595, a first-in-class naphthyridine analog that intercalates DNA and poisons topoisomerase II causing selective DNA
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... St. Louis, MO (PRWEB) , ... July 31, 2015 , ... ... litigation* currently underway in U.S. District Court in the Northern District of Illinois, Androgel ... documents. On Monday, July 20, a docket entry was made recording the minutes of ...
(Date:7/31/2015)... ... July 31, 2015 , ... People ... when purchasing disability insurance, where price is an important factor to clients when ... leading insurance carrier, offers the Preferred Producer Multi-Life Discount program, where advisers pass ...
(Date:7/30/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... Floor:, Reduce Errors By 50% or More, **Presented by FDAnews and Ginette M. ... Ginette Collazo, a 15 year veteran of helping drug, biologic and device firms ...
(Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... program entitled " Lovetraction Lines ." It's for women interested in improving their ... they desire. The course, which officially launched to the public early this morning, ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 2Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 4Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2
... ... bomb is to explode in the coming years , ... London, UK (PRWEB) June 13, 2009 -- New images released by Lloydspharmacy show how ... affects around a quarter of the UK population, one of the highest prevalence rates for hayfever ...
... Calif., June 12 An independent factfinder jointly hired by Fresno ... County,s plan to cut the wages and benefits of 10,000 home ... and ordered that the cuts be halted. The Fresno Board of ... Tuesday. , , SEIU UHW invoked their right to arbitration ...
... Customs Enforcement Slow to Act, Not Doing Enough to Protect Employees, ... and Customs Enforcement Krome Service Processing Center in Miami, FL has ... has urged the agency for weeks to fit its personnel with ... with the H1N1 virus. "This is an outrage that it ...
... Ill., June 12 The American College of Chest ... historic 79-17 vote yesterday and the U.S. House of ... Food and Drug Administration meaningful authority to regulate tobacco ... represents the strongest legislation Congress has ever passed to ...
... says , FRIDAY, June 12 (HealthDay News) -- Here,s more ... about 4 percent of males develop dry eye disease, making ... for seeing an eye doctor in the United States, researchers ... or burning sensation in the eyes, according to the North ...
... ... largest online retailer of vision care products, unveils the newest addition to its collection ... organic, recycled material making them an environmentally friendly choice. , ... Vancouver, BC (PRWEB) - Clearly Contacts, the ...
Cached Medicine News:Health News:Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 2Health News:Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 3Health News:Neutral Factfinder Rules That Fresno County Home Care Wage Cuts Should Be Stopped 2Health News:Krome Immigration Service Processing Center Has Confirmed H1N1 Flu Cases 2Health News:American College of Chest Physicians Celebrates the Nation's Victory for Tobacco Control 2Health News:For Men Over 50, Odds of Eye Discomfort Increases 2Health News:Clearly Contacts Goes Green With Organic Glasses 2
(Date:7/31/2015)... 2015 Magnaquest, a leading ... and cloud computing operators has signed a Proof ... for Internet of Things (IoT) related initiative. The ... subscription model.      (Logo: http://photos.prnewswire.com/prnh/20140807/700645 ... for business innovations to make healthcare services more ...
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... an Interventional Radiology Treatment -- Detailed for Those ... Osteoplasty -- a highly effective minimally invasive procedure ... disease by injecting bone cement to support weakened ... often presenting individuals who are suffering terribly with ...
... Any Age: Comparison by Interventional Radiologists Shows No ... FistulasSAN DIEGO, March 9 A new study ... disease, it doesn,t matter if you,re young or ... for maintaining access to one,s circulatory system to ...
Cached Medicine Technology:Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 2Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 3Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 4Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 5For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 2For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 3For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 4
Inquire...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
Inquire...
... Scientific PSE Power Supply . The digital ... V and 2 A in 1 volt and ... run up to three SEA 2000® apparatus simultaneously ... preset and actual values of voltage, current and ...
Medicine Products: